Clinical trials
Immunologic Deficiency Syndromes trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2010 | 2 |
| 2012 | 2 |
| 2016 | 2 |
| 2018 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Terminated | 3 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Masonic Cancer Center, University of Minnesota | 2 |
| Centagen, Inc. | 1 |
| Fairview University Medical Center | 1 |
| Goddess Zena I. Jones | 1 |
| National Center for Research Resources (NCRR) | 1 |
| Rockefeller University | 1 |
| Scripps Translational Science Institute | 1 |
| Sumitomo Pharma Switzerland GmbH | 1 |
| University of Maryland, College Park | 1 |
| University of South Florida | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunologic Deficiency Syndromes | 12 |
| Anemia, Sickle Cell | 2 |
| Chediak-Higashi Syndrome | 2 |
| Common Variable Immunodeficiency | 2 |
| Graft vs Host Disease | 2 |
| Granulomatous Disease, Chronic | 2 |
| HIV Infections | 2 |
| Hematologic Diseases | 2 |
| Histiocytosis, Langerhans-Cell | 2 |
| Immune System Diseases | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.